// App-Quantinova.ai

: PACE-A: An international phase 3 randomised controlled trial (RCT) comparing stereotactic body radiotherapy (SBRT) to surgery for localised prostate cancer (LPCa)—Primary endpoint analysis.

Researchers

Presenter

  • Nicholas John Van As

Principal Investigators

  • Peter James Ostler

  • Hans van der Voet

  • Daniel Ford

  • Shaun Tolan

  • Paula Wells

  • Rana Mahmood

  • Mathias Winkler

  • Andrew Chan

  • Alan Thompson

  • Christopher Ogden

  • Stephanie Brown

  • Julia Pugh

  • Stephanie M. Burnett

  • Clare Griffin

  • Jaymini Patel

  • Olivia Naismith

  • Emma Hall

Medical Centers

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Anaesthetics, Colchester General Hospital, Colchester,United Kingdom

  • Charing Cross Hospital, London, United Kingdom

  • University Hospitals Coventry and Warwickshire NHS Trust, Coventry, United Kingdom

  • Radiotherapy Trials Quality Assurance (RTTQA), Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Queen Elizabeth Hospital, Birmingham, United Kingdom

  • Mount Vernon Hospital, Dunstable, United Kingdom

  • Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, United Kingdom

  • Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom

  • James Cook University Hospital, Middlesborough, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Urology

  • Oncology (ONC)

Disease

  • Bladder dysfunction

  • Prostate cancer

  • Solid malignancies

Biomarkers

  • Prostate specific antigen

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Open Label

  • Multinational

  • Controlled

  • Cohort

Phase

  • III

Study Id's

  • NCT01584258

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved